Dosing strategies for MLN8054, a selective Aurora A kinase inhibitor, based on pharmacokinetic modeling and simulations

  1. Lee, Y.
  2. Eton, O.
  3. Pappas, J.
  4. Chen, S.
  5. Paton, M.
  6. Dees, E. C.
  7. Jones, S.
  8. Cohen, R. B.
  9. Cervantes, A.
  10. Tabernero, J.
Revista:
EJC SUPPLEMENTS

ISSN: 1359-6349

Ano de publicación: 2008

Volume: 6

Número: 12

Páxinas: 130-131

Congreso: 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

Tipo: Achega congreso

DOI: 10.1016/S1359-6349(08)72349-8 GOOGLE SCHOLAR